BRETISILOCIN
UNII DS425RQ8SX

Substance Identification & Data

This profile provides standardized clinical and technical data for Bretisilocin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DS425RQ8SX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2698331-35-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DS425RQ8SX

CAS Registry Number

2698331-35-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRETISILOCIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H17FN2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XRWQULAXCLVBPP-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C216012

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

156836209

Unique identification number in the NCBI database of chemical substances.

INN ID

13447

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(CN(CC)C)c1c2c([nH]c1)ccc(F)c2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bretisilocin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.